PYNKF Overview

Adoption of Advanced Imaging Technology: Perimeter Medical Imaging AI, Inc. announced that HCA HealthONE Rose in Colorado is the first in the state to adopt its S-Series OCT technology for enhanced tissue visualization during surgeries.

Benefits of S-Series OCT: The S-Series OCT provides real-time, high-resolution imaging at the cellular level, allowing surgeons to make informed decisions without waiting for pathology results, potentially reducing the need for additional procedures.

Company Background: Perimeter Medical Imaging AI is focused on transforming cancer surgery with advanced imaging tools and is awaiting regulatory decisions on its next-generation B-Series OCT technology, which integrates artificial intelligence.

Forward-Looking Statements: The announcement includes forward-looking statements regarding the company's future outlook, financial position, and anticipated events, emphasizing the inherent uncertainties and risks involved.

Financial Performance: Perimeter Medical Imaging AI reported a 157% increase in Q3-2025 revenue year-over-year, totaling $536,000, while operating expenses decreased by 34% compared to the previous year, leading to a net loss improvement of 42%.

Product Development: The company is advancing its next-generation Perimeter B-Series device, which incorporates AI technology, and anticipates a regulatory decision from the FDA in the first half of 2026.

Market Adoption: The Perimeter S-Series device has gained significant traction, with over 3,500 patients imaged and increasing usage among top medical centers, enhancing awareness for the upcoming B-Series.

Corporate Updates: Perimeter has made key appointments to its leadership team and established an Industry Advisory Board to support growth strategies, while also launching an OCT-Tissue Surveillance Registry to inform future product development.

Financial Results Announcement: Perimeter Medical Imaging AI, Inc. will report its third quarter 2025 financial and operating results on November 12, 2025, followed by a webcast and conference call for discussion.

Company Overview: Perimeter is a medical technology company focused on transforming cancer surgery with advanced imaging tools, including the FDA-cleared Perimeter S-Series OCT system and the investigational Perimeter B-Series OCT with ImgAssist AI.

Regulatory Status: The Perimeter B-Series OCT is currently limited to investigational use in the U.S. and is not available for sale, while the S-Series OCT has received 510(k) clearance but has not been specifically evaluated for certain cancer-related uses.

Contact Information: For inquiries, the press release provides contact details for Stephen Kilmer (Investor Relations) and Adrian Mendes (CEO) along with their respective phone numbers and email addresses.

Perimeter Medical Imaging AI Participation: Perimeter Medical Imaging AI, Inc. is participating in the American Society of Breast Surgeons' Annual Strategic Futures Forum to engage with leaders in breast surgery and enhance patient care through collaborative discussions.

Focus on Multi-Disciplinary Collaboration: The Forum's theme, "Building the Breast Care Team," emphasizes the importance of integrated teams in improving breast care outcomes, involving various healthcare professionals.

Innovative Imaging Technology: Perimeter offers advanced imaging tools, including the FDA-cleared Perimeter S-Series OCT system and the investigational Perimeter B-Series OCT with ImgAssist AI, aimed at transforming cancer surgery.

Forward-Looking Statements: The news release includes forward-looking statements regarding Perimeter's future strategies, potential benefits of its products, and anticipated regulatory approvals, highlighting inherent uncertainties and risks.

Company Presentation: Perimeter Medical Imaging AI, Inc. will have its CEO, Adrian Mendes, present a company update on commercial strategy and milestones at the Planet MicroCap Showcase on October 22, 2025.

Innovative Technology: The company focuses on transforming cancer surgery with advanced imaging tools, including the FDA-cleared Perimeter S-Series OCT system and the investigational Perimeter B-Series OCT with ImgAssist AI, which is currently under clinical evaluation.

Event Announcement: The Small Cap Growth Virtual Investor Conference is scheduled for October 16, 2025, inviting individual and institutional investors to participate in live presentations and one-on-one meetings with company management at no cost.

Company Presentations: The conference will feature a diverse lineup of companies, including Crushmetric, Zapp Electric Vehicles, and Hillcrest Energy Technologies, with scheduled presentations throughout the day.